Avandia Panelist Issue Sent To HHS Inspector General
The U.S. Food and Drug Administration has asked the inspector general of the Department of Health and Human Services to look into concerns that one of its advisory panelists who voted...To view the full article, register now.
Already a subscriber? Click here to view full article